SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-24-000818
Filing Date
2024-02-06
Accepted
2024-02-06 17:01:02
Documents
50
Period of Report
2024-02-06
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K apre-20240206x8k.htm   iXBRL 8-K 38881
2 EX-99.1 apre-20240206xex99d1.htm EX-99.1 52510
3 GRAPHIC apre-20240206xex99d1g001.jpg GRAPHIC 106682
4 GRAPHIC apre-20240206xex99d1g002.jpg GRAPHIC 335203
5 GRAPHIC apre-20240206xex99d1g003.jpg GRAPHIC 171668
6 GRAPHIC apre-20240206xex99d1g004.jpg GRAPHIC 146116
7 GRAPHIC apre-20240206xex99d1g005.jpg GRAPHIC 176174
8 GRAPHIC apre-20240206xex99d1g006.jpg GRAPHIC 56541
9 GRAPHIC apre-20240206xex99d1g007.jpg GRAPHIC 148590
10 GRAPHIC apre-20240206xex99d1g008.jpg GRAPHIC 175399
11 GRAPHIC apre-20240206xex99d1g009.jpg GRAPHIC 110753
12 GRAPHIC apre-20240206xex99d1g010.jpg GRAPHIC 130321
13 GRAPHIC apre-20240206xex99d1g011.jpg GRAPHIC 128796
14 GRAPHIC apre-20240206xex99d1g012.jpg GRAPHIC 110173
15 GRAPHIC apre-20240206xex99d1g013.jpg GRAPHIC 57428
16 GRAPHIC apre-20240206xex99d1g014.jpg GRAPHIC 175777
17 GRAPHIC apre-20240206xex99d1g015.jpg GRAPHIC 135941
18 GRAPHIC apre-20240206xex99d1g016.jpg GRAPHIC 143061
19 GRAPHIC apre-20240206xex99d1g017.jpg GRAPHIC 59075
20 GRAPHIC apre-20240206xex99d1g018.jpg GRAPHIC 179037
21 GRAPHIC apre-20240206xex99d1g019.jpg GRAPHIC 176645
22 GRAPHIC apre-20240206xex99d1g020.jpg GRAPHIC 141129
23 GRAPHIC apre-20240206xex99d1g021.jpg GRAPHIC 163780
24 GRAPHIC apre-20240206xex99d1g022.jpg GRAPHIC 58659
25 GRAPHIC apre-20240206xex99d1g023.jpg GRAPHIC 167579
26 GRAPHIC apre-20240206xex99d1g024.jpg GRAPHIC 91072
27 GRAPHIC apre-20240206xex99d1g025.jpg GRAPHIC 61166
28 GRAPHIC apre-20240206xex99d1g026.jpg GRAPHIC 125043
29 GRAPHIC apre-20240206xex99d1g027.jpg GRAPHIC 167241
30 GRAPHIC apre-20240206xex99d1g028.jpg GRAPHIC 140367
31 GRAPHIC apre-20240206xex99d1g029.jpg GRAPHIC 117201
32 GRAPHIC apre-20240206xex99d1g030.jpg GRAPHIC 135489
33 GRAPHIC apre-20240206xex99d1g031.jpg GRAPHIC 96173
34 GRAPHIC apre-20240206xex99d1g032.jpg GRAPHIC 161431
35 GRAPHIC apre-20240206xex99d1g033.jpg GRAPHIC 114546
36 GRAPHIC apre-20240206xex99d1g034.jpg GRAPHIC 148704
  Complete submission text file 0001558370-24-000818.txt   6591341

Data Files

Seq Description Document Type Size
37 EX-101.SCH apre-20240206.xsd EX-101.SCH 3993
38 EX-101.DEF apre-20240206_def.xml EX-101.DEF 2842
39 EX-101.LAB apre-20240206_lab.xml EX-101.LAB 17243
40 EX-101.PRE apre-20240206_pre.xml EX-101.PRE 11353
51 EXTRACTED XBRL INSTANCE DOCUMENT apre-20240206x8k_htm.xml XML 4811
Mailing Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902
Business Address 3805 OLD EASTON ROAD DOYLESTOWN PA 18902 617-463-9385
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39069 | Film No.: 24601060
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)